The future of
Linkster Therapeutics raises the bar on in vivo antibody development to create precision medicines for the right target, the right tissue & the right patient.
We revolutionise drug development with translational antibody engineering, in vivo & in high-throughput.
We ensure targeted delivery to the disease site and avoid off-target effects.
We perform pharmacology profiling 500-times faster and right at the start of early discovery.